KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Cash & Equivalents (2016 - 2026)

Silicon Laboratories has reported Cash & Equivalents over the past 18 years, most recently at $364.2 million for Q1 2026.

  • Quarterly results put Cash & Equivalents at $364.2 million for Q1 2026, up 29.34% from a year ago — trailing twelve months through Jan 2026 was $364.2 million (up 29.34% YoY), and the annual figure for FY2026 was $364.2 million, up 29.34%.
  • Cash & Equivalents for Q1 2026 was $364.2 million at Silicon Laboratories, up from $341.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SLAB hit a ceiling of $1.1 billion in Q1 2022 and a floor of $159.9 million in Q3 2023.
  • Median Cash & Equivalents over the past 5 years was $324.9 million (2025), compared with a mean of $413.5 million.
  • Biggest five-year swings in Cash & Equivalents: soared 430.1% in 2022 and later crashed 73.27% in 2024.
  • Silicon Laboratories' Cash & Equivalents stood at $499.9 million in 2022, then tumbled by 54.49% to $227.5 million in 2023, then grew by 23.78% to $281.6 million in 2024, then increased by 21.23% to $341.4 million in 2025, then increased by 6.68% to $364.2 million in 2026.
  • The last three reported values for Cash & Equivalents were $364.2 million (Q1 2026), $341.4 million (Q4 2025), and $314.5 million (Q3 2025) per Business Quant data.